Regulation of IGFBP-1 in humans

Progress in Growth Factor Research

Volumn 6, Issue 2-4, 1995, Pages 449-456

  Brismar, Kerstin ^a   Hilding, Agneta ^a   Lindgren, Björn ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

clearance; diabetes mellitus; human; IGFBP 1; insulin resistance; lymph; population studies; production rate; serum

Indexed keywords

INSULIN; SOMATOMEDIN BINDING PROTEIN 1;

DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GENETICS; HUMAN; INSULIN RESISTANCE; LYMPH; MALE; METABOLIC CLEARANCE RATE; METABOLISM; PHYSIOLOGY; REVIEW; SECRETION;

DIABETES MELLITUS; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LYMPH; MALE; METABOLIC CLEARANCE RATE;

EID: 0029433746     PISSN: 09552235     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2235(96)00006-3     Document Type: Article

References (33)

1. Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid
2. Cross-reaction of serum somatomedin-binding protein isolated from human amniotic fluid in a radioimmunoassay developed for somatomedin-binding protein
3. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus
4. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
5. Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin?
6. Lack of diurnal rhythm of low molecular weight insulin-like growth factor binding protein in patients with Cushing's disease
7. Clinical applications of IGFBP-1 and its regulation.
8. IGFBP-1 regulation during insulin infusion: comparison between type 2 and type 1 diabetics
9. IGFBP-1 during insulin infusion to type 2 diabetes patients with renal failure
10. The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment
11. The effect of insulin on the hepatic secretion of IGFBP-1, IGFBP-3 and IGF-1 in insulin-dependent diabetes
12. The effect of insulin on the hepatic secretion of IGFBP-1 and IGF-I in humans
13. Multi hormonal regulation of phosphoenolpyruvate carboxykinase-chloramphenical acetyltransferose fusion genes. Insulin's effects oppose those of cAMP and dexamethasone
14. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart
15. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid (IGFBP-1) IGF-binding proteins in the rat heart
16. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans
17. Inhibitors of glucose uptake stimulate the production of insulin-like growth factor binding protein (IGFBP-1) by human fetal liver
18. Glucagon stimulates insulin-like growth-factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus
19. Circulating epinephrine stimulates the secretion of IGFBP-1 in humans
20. Genetic and environmental effects on IGFBP-1 levels in adult twins
21. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects
22. Decreased hepatic insulin extraction in upper body obesity: relationship to unbound androgens and sex hormone binding globulin
23. Disturbed anabolic hormonal patterns in burned patients—the relation to glucagon
24. Insulin-like growth factor binding protein-1 is selectively upregulated during routine hemodialysis while insulin and insulin-like growth factor I remain constant
25. All products of proglucagon are elevated in plasma from uremic patients
26. Fasting affects serum insulin-like growth factors (IGFs) and IGF binding proteins differently in patients with NIDDM versus healthy non-obese and obese, weight matched subjects
27. Insulin-like growth factor-I and IGF-binding protein-1 in a representative NIDDM population
28. Glyburide decreases insulin requirement, increases B-cell response to mixed meal, and does not affect insulin sensitivity. Effects of short- and long-term combined treatment in secondary failure to sulfonylurea
29. Paradoxical IGFBP1 response to meal-related hyperinsulinemia in type-2 diabetes
30. Insulin-like growth factor binding-protein-1 modulates blood glucose levels
31. Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men